| scholarly article | Q13442814 |
| P2093 | author name string | Yu Chen | |
| Rui Fu | |||
| Ming-Xian Chen | |||
| Qin-Qin Yang | |||
| Sai-Yue Liu | |||
| Tang-Biao Shen | |||
| P2860 | cites work | The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatments | Q26739291 |
| A role of periaqueductal grey NR2B-containing NMDA receptor in mediating persistent inflammatory pain | Q33578684 | ||
| Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings. | Q33851444 | ||
| Central and peripheral hypersensitivity in the irritable bowel syndrome. | Q34033753 | ||
| Review article: the economic impact of the irritable bowel syndrome | Q34041951 | ||
| Irritable bowel syndrome: new agents targeting serotonin receptor subtypes | Q34212885 | ||
| Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed | Q34612294 | ||
| Differential effects of glutamate receptor antagonists on dorsal horn neurons responding to colorectal distension in a neonatal colon irritation rat model | Q35165975 | ||
| Pathophysiologic findings of irritable bowel syndrome in china | Q35730488 | ||
| Irritable bowel syndrome: a model of the brain-gut interactions | Q35839435 | ||
| Neuromodulatory processes of the brain-gut axis | Q37390659 | ||
| Infection, inflammation, and the irritable bowel syndrome | Q37589116 | ||
| Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome | Q37871421 | ||
| Physiological, pathophysiological and therapeutic impact of the enteric serotonergic system | Q37995969 | ||
| Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. | Q38024260 | ||
| Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome | Q38178543 | ||
| Underlying molecular and cellular mechanisms in childhood irritable bowel syndrome | Q38515695 | ||
| Downregulation of the spinal NMDA receptor NR2B subunit during electro-acupuncture relief of chronic visceral hyperalgesia | Q39172190 | ||
| Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials | Q39397861 | ||
| Amitriptyline enhances extracellular tissue levels of adenosine in the rat hindpaw and inhibits adenosine uptake | Q40374840 | ||
| Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. | Q42462847 | ||
| Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats | Q42844036 | ||
| Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome | Q43746131 | ||
| T-cell activation in patients with irritable bowel syndrome | Q43864301 | ||
| Tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord contributes to chronic visceral pain in rats | Q44762084 | ||
| Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain | Q45815924 | ||
| Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome | Q46431252 | ||
| Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome | Q46885942 | ||
| Spinal cord long-term potentiation is attenuated by the NMDA-2B receptor antagonist Ro 25-6981. | Q46923513 | ||
| Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? | Q46939907 | ||
| Imbalance of tumor necrosis factor-α, interleukin-8 and interleukin-10 production evokes barrier dysfunction, severe abdominal symptoms and psychological disorders in patients with irritable bowel syndrome-associated diarrhea | Q48078265 | ||
| A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development | Q73130772 | ||
| Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff | Q84145763 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | irritable bowel syndrome | Q838966 |
| P304 | page(s) | 5580-5590 | |
| P577 | publication date | 2016-12-15 | |
| P1433 | published in | American Journal of Translational Research | Q4744272 |
| P1476 | title | Activation of 5-HT and NR2B contributes to visceral hypersensitivity in irritable bowel syndrome in rats | |
| P478 | volume | 8 |
| Q48335208 | Ameliorative effect of chlorpromazine hydrochloride on visceral hypersensitivity in rats: possible involvement of 5-HT2A receptor |
| Q64248522 | Effect of Electroacupuncture at Different Acupoints on the Expression of NMDA Receptors in ACC and Colon in IBS Rats |
| Q57819633 | MicroRNA-200a Targets Cannabinoid Receptor 1 and Serotonin Transporter to Increase Visceral Hyperalgesia in Diarrhea-predominant Irritable Bowel Syndrome Rats |
Search more.